{"entity":{"type":"insider","cik":"0001960048","url":"/insider/0001960048","json_url":"/insider/0001960048.json","name":"Cowan Elvia","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":8,"first":"2024-03-04","last":"2026-04-08","span_basis":"filed_date"},"name_variants":[{"name":"Cowan Elvia","source":"filing","n_filings":8,"first_seen":"2024-03-04","last_seen":"2026-04-08"}],"transactions":[{"id":6083566,"accession":"0001960048-26-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001960048-26-000007","line_url":"/filing/0001960048-26-000007#line-2","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001960048","owner_name":"Cowan Elvia","owner_display_name":"Cowan Elvia","owner_url":"/insider/0001960048","role":"Officer (SVP, Finance & CAO)","role_mark":"O","role_mark_label":"Officer (SVP, Finance & CAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Finance & CAO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":60.0,"price_display":"60.00","price_state":"stated","total_value":180000.0,"total_display":"180,000.00","total_whole":"180,000","shares_owned_after":28975.0,"shares_owned_after_display":"28,975","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-07","filed_date":"2026-04-08","scope":"insider"},{"id":6121288,"accession":"0001960048-26-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001960048-26-000005","line_url":"/filing/0001960048-26-000005","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001960048","owner_name":"Cowan Elvia","owner_display_name":"Cowan Elvia","owner_url":"/insider/0001960048","role":"Officer (SVP, Finance & CAO)","role_mark":"O","role_mark_label":"Officer (SVP, Finance & CAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Finance & CAO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1892.0,"shares_display":"1,892","price_per_share":55.574515856236786,"price_display":"55.57","price_state":"stated","total_value":105146.984,"total_display":"105,146.98","total_whole":"105,147","shares_owned_after":29380.0,"shares_owned_after_display":"29,380","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-17","filed_date":"2026-03-18","scope":"insider","n_lines":2},{"id":6101568,"accession":"0001960048-26-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001960048-26-000004","line_url":"/filing/0001960048-26-000004#line-3","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001960048","owner_name":"Cowan Elvia","owner_display_name":"Cowan Elvia","owner_url":"/insider/0001960048","role":"Officer (SVP, Finance & CAO)","role_mark":"O","role_mark_label":"Officer (SVP, Finance & CAO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Finance & CAO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":58.5927,"price_display":"58.59","price_state":"stated","total_value":146481.75,"total_display":"146,481.75","total_whole":"146,482","shares_owned_after":30867.0,"shares_owned_after_display":"30,867","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-11","filed_date":"2026-03-11","scope":"insider"},{"id":5101501,"accession":"0001960048-25-000010","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001960048-25-000010","line_url":"/filing/0001960048-25-000010","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001960048","owner_name":"Cowan Elvia","owner_display_name":"Cowan Elvia","owner_url":"/insider/0001960048","role":"Officer (SVP, FINANCE)","role_mark":"O","role_mark_label":"Officer (SVP, FINANCE)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, FINANCE","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11623.0,"shares_display":"11,623","price_per_share":47.91980151423901,"price_display":"47.92","price_state":"stated","total_value":556971.853,"total_display":"556,971.85","total_whole":"556,972","shares_owned_after":14534.0,"shares_owned_after_display":"14,534","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-23","filed_date":"2025-12-29","scope":"insider","n_lines":2},{"id":2292932,"accession":"0001649094-24-000063","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001649094-24-000063","line_url":"/filing/0001649094-24-000063#line-3","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001960048","owner_name":"Cowan Elvia","owner_display_name":"Cowan Elvia","owner_url":"/insider/0001960048","role":"Officer (SVP, FINANCE)","role_mark":"O","role_mark_label":"Officer (SVP, FINANCE)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, FINANCE","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":107.67,"price_display":"107.67","price_state":"stated","total_value":538350.0,"total_display":"538,350.00","total_whole":"538,350","shares_owned_after":12723.0,"shares_owned_after_display":"12,723","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-03","filed_date":"2024-09-05","scope":"insider"},{"id":2123973,"accession":"0001649094-24-000036","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001649094-24-000036","line_url":"/filing/0001649094-24-000036#line-2","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001960048","owner_name":"Cowan Elvia","owner_display_name":"Cowan Elvia","owner_url":"/insider/0001960048","role":"Officer (SVP, FINANCE)","role_mark":"O","role_mark_label":"Officer (SVP, FINANCE)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, FINANCE","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":85.0,"price_display":"85.00","price_state":"stated","total_value":425000.0,"total_display":"425,000.00","total_whole":"425,000","shares_owned_after":12723.0,"shares_owned_after_display":"12,723","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-16","filed_date":"2024-07-17","scope":"insider"},{"id":2705592,"accession":"0001649094-24-000034","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001649094-24-000034","line_url":"/filing/0001649094-24-000034#line-2","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001960048","owner_name":"Cowan Elvia","owner_display_name":"Cowan Elvia","owner_url":"/insider/0001960048","role":"Officer (SVP, FINANCE)","role_mark":"O","role_mark_label":"Officer (SVP, FINANCE)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, FINANCE","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":80.0,"price_display":"80.00","price_state":"stated","total_value":400000.0,"total_display":"400,000.00","total_whole":"400,000","shares_owned_after":12723.0,"shares_owned_after_display":"12,723","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-08","filed_date":"2024-07-09","scope":"insider"},{"id":3235216,"accession":"0001415889-24-006475","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001415889-24-006475","line_url":"/filing/0001415889-24-006475","is_derivative":false,"issuer_cik":"0001649094","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001649094","owner_cik":"0001960048","owner_name":"Cowan Elvia","owner_display_name":"Cowan Elvia","owner_url":"/insider/0001960048","role":"Officer (SVP, FINANCE)","role_mark":"O","role_mark_label":"Officer (SVP, FINANCE)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, FINANCE","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11678.0,"shares_display":"11,678","price_per_share":74.07693466346977,"price_display":"74.08","price_state":"stated","total_value":865070.443,"total_display":"865,070.44","total_whole":"865,070","shares_owned_after":12480.0,"shares_owned_after_display":"12,480","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-01","filed_date":"2024-03-04","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001649094","name":"Vaxcyte, Inc.","url":"/issuer/0001649094","role":"Officer (SVP, Finance & CAO)","n_filings":8,"first_seen":"2024-03-04","last_seen":"2026-04-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001960048","retrieved_at":"2026-08-26T20:20:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}